Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > WHO kicks Remdesivir To The Curb
View:
Post by Raddnar on Nov 20, 2020 1:48am

WHO kicks Remdesivir To The Curb

With no treatments available, and Ifenprodil the next in line to release data, if positive, Ifenprodil will continue to be ahead of all other treatments.

https://www.google.com/amp/s/www.nytimes.com/2020/11/19/health/Covid-WHO-remdesivir.amp.html
Comment by samrak on Nov 20, 2020 10:27am
Possibly.  Remdesivir certainly seems to have a limited effect.  However it isn't the only potential competing treatment.  Fluvoxamine might have promise.  Small study but numbers looked decent.  Not really much of an investment thesis though. Nitric oxide has some positive indications.  Tricky stuff to use though.
Comment by Pandora on Nov 20, 2020 12:43pm
Don't discount Cytodyn (CYDY)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities